FDA Approvals - Genentech Announces Second Quarter 2006 Results (FinanzNachrichten) SOUTH SAN FRANCISCO,
Genentech Announces Second Quarter 2006 Results (FinanzNachrichten)
SOUTH SAN FRANCISCO, Calif., July 11 /PRNewswire-FirstCall/ -- Genentech, ( Nachrichten ) Inc. today announced financial results for the second quarter of 2006. Revenue results for the second quarter of 2006 include:
FDA Approves Abiomed's New Integrated Off-Pump Cannula; New Cannula to Standardize and Enhance Ventricular Assist (RedNova)
Abiomed, Inc. (NASDAQ: ABMD) today announced U.S. Food and Drug Administration (FDA) approval of its Premarket Approval Application (PMA) supplement for the Company's new integrated cannula system.
Genentech Announces Second Quarter 2006 Results (PR Newswire via Yahoo! Finance)
Genentech, Inc. today announced financial results for the second quarter of 2006.